The immune system in the oxidative stress conditions of aging and hypertension: Favorable effects of antioxidants and physical exercise

Antioxidants and Redox Signaling

Volumn 7, Issue 9-10, 2005, Pages 1356-1366

  De La Fuente, Mónica ^a   Hernanz, A ^b   Vallejo, M C ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; INTERLEUKIN 2; SUPEROXIDE DISMUTASE;

AGING; DIET SUPPLEMENTATION; EXERCISE; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFLAMMATION; INTRACELLULAR TRANSPORT; LONGEVITY; OXIDATION KINETICS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SENESCENCE;

AGING; ANTIOXIDANTS; ASCORBIC ACID; CELL PROLIFERATION; CHEMOTAXIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HUMANS; HYPERTENSION; IMMUNE SYSTEM; INTERLEUKIN-2; K562 CELLS; KILLER CELLS, NATURAL; LEUKOCYTES; LYMPHOCYTES; MODELS, BIOLOGICAL; NEUTROPHILS; OXIDATIVE STRESS;

EID: 24144436152     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.1356     Document Type: Review

References (88)

1. Ader R, Feiten DL, and Cohen N (Eds). Psychoneuroimmunology. San Diego, CA: Academic Press, 2001.
2. Aviv A. Chronology versus biology: telomeres, essential hypertension, and vascular aging. Hypertension 40: 229-232, 2002.
3. Bayorth MA, Ganafa AA, Socci RR, Silvestro N, and Abukhalaf IK. The role of oxidative stress in salt-induced hypertension Am J Hypertens 17: 31-36, 2004.
4. Benfante R, Reed R, and Brody J. Biological and social predictors of health in an aging cohort. J Chronic Dis 38: 175-181, 1985.
5. Black HR. New concept in hypertension: focus on the elderly. Am Heart J 135: S2-S7, 1998.
6. Cristofori P, Lanzoni A, Quartoli M, Pastorino AM, Zanccanaro C, Cominacini L, Gaviraghi G, and Turton J. The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the ApoE-deficient mouse. J Hypertens 18: 1429-1436, 2000.
7. De la Fuente M. Effects of antioxidants on immune system ageing. Eur J Clin Nutr 56: S5-S8, 2002.
8. De la Fuente M, Hernanz A, Collazos ME, Barriga C, and Ortega E. Effect of physical exercise and aging on ascorbic acid and superoxide anion levels in peritoneal macrophages from mice and guinea pigs. J Comp Physiol [B] 165: 315-319, 1995.
9. De la Fuente M, Del Rio M, and Medina M. Changes with aging in the modulation by neuropeptide Y of murine peritoneal macrophage functions. J Neuroimmunol 116: 156-167, 2001.
10. De la Fuente M, Miquel J, Catalan MP, Victor VM, and Guayerbas N. The amount of thiolic antioxidant ingestion needed to improve several immune functions is higher in aged than in adult mice. Free Radic Res 36: 119-126, 2002.
11. De la Fuente M, Hernanz A, Guayerbas N, Alvarez P, Puerto M, and Alvarado C. Changes with age in peritoneal macrophage functions. Implication of leukocytes in oxidative stress of senescence. Cell Mol Biol (Noisy-le-grand) 50: OL683-698, 2004.
12. Drewnowski A and Evans WJ. Nutrition, physical activity, and quality of life in older adults: summary. J Gerontol A Biol Sci Med Sci 56: 89-94, 2001.
13. Droge W. Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol 37: 1331-1343, 2002.
14. Ehsani AA. Exercise in patients with hypertension. Am J Geriatr Cardiol 10: 253-259, 2001.
15. Fabris N. Neuroendocrine-immune interactions: a theoretical approach to ageing. Arch Gerontol Geriatr 12: 219-230, 1991.
16. Ferrandez MD and De la Fuente M. Effect of age, sex and physical exercise on the phagocytic process of murine peritoneal macrophages. Acta Physiol Scand 166: 47-53, 1999.
17. Ferrer M, Sánchez M, Minoves N, Salaices M, and Balzagón G. Aging increases neuronal nitric oxide release and superoxide anion generation in mesenteric arteries from spontaneous hypertensive rats. J Vasc Res 40: 509-519, 2003.
18. Forsberf L, de Faire U, and Morgenstern R. Oxidative stress, human genetic variation and disease. Arch Biochem Biophys 389: 84-93, 2001.
19. Gabriel HHW, Heine G, Kroger K, Ratz M, Lichtenstern C, Schmitz A, and Kindermann W. Exercise and atherogenesis: where is the missing link? Exerc Immunol Rev 5: 96-102, 1999.
20. Gey KF. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease. Br Med Bull 49: 679-699, 1993.
21. Guayerbas N and De la Fuente M. An impairment of phagocytic function is linked to a shorter life span in two strains of prematurely aging mice. Dev Comp Immunol 27: 339-350, 2003.
22. Guayerbas N, Catalan M, Victor VM, Miquel J, and De la Fuente M. Relation of behaviour and macrophage function to life span in a murine model of premature immunosenescence. Behav Brain Res 134: 41-48, 2002.
23. Guayerbas N, Puerto M, Ferrández MD, and De la Fuente M. A diet supplemented with thiolic anti-oxidants improves leukocyte function in two strains of prematurely ageing mice. Clin Exp Pharmacol Physiol 29: 1009-1014, 2002.
24. Guayerbas N, Puerto M, Victor VM, Miquel J, and De la Fuente M. Leukocyte function and life span in a murine model of premature immunosenescence. Exp Gerontol 37: 249-256, 2002.
25. Gudbrandsson T, Herlitz H, Hansson L, Lindholm L, and Nilsson LA. Immunological changes in patients with previous malignant essential hypertension. Lancet 317: 406-408, 1981.
26. Haennel RG and Lemire F. Physical activity to prevent cardiovascular disease. How much is enough? Can Fam Physician 48: 65-71, 2002.
27. Hagberg JM, Park JJ, and Brown MD. The role of exercise training in the treatment of hypertension: an update. Sports Med 30: 193-206, 2002.
28. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, and Dominicazk AF. Superoxide excess in hypertension and aging. A common cause of endothelial dysfunction. Hypertension 37: 529-534, 2001.
29. Harman D. Aging: a theory based on free radicals and radiation chemistry. J Gerontol 11: 298-300, 1956.
30. Harman D. Free radical theory of aging: role of free radicals in the origination and evolution of life, aging and disease processes. In: Free Radicals, Aging and Degenerative Diseases, edited by Johnson JE Jr, Walford R, Harman D, and Miquel J. New York: Alan R. Liss, 1986, pp. 3-49.
31. Harman D. Free-radical theory of aging. Increasing the functional life span. Ann N Y Acad Sci 717: 1-15, 1994.
32. Hernanz A, Fernández-Vivancos E, Montiel C, Vázquez JJ, and Arnalich F. Changes in the intracellular homocysteine and glutathione content associated with aging. Life Sci 67: 1317-1324, 2000.
33. Inal ME, Kanback G, and Sunal E. Antioxidant enzyme activities and malondialdehyde levels related to aging. Clin Chim Act 305: 75-80, 2001.
34. Ito H, Torii M, and Suzuki T. Comparative study on free radical injury in the endothelium of SHR and WKY aorta. Clin Exp Pharmacol Physiol 1: S157-S159, 1995.
35. Johnson P. Antioxidant enzyme expression in health and disease: effects of exercise and hypertension. Comp Biochem Physiol C 133: 493-505, 2002
36. Kitiyakara C and Wilcox CS. Antioxidants for hypertension. Curr Opin Nephrol Hypertens 7: 531-538, 1998.
37. Kitts DD, Yuan YV, and Godin DV. Plasma and lipoprotein lipid composition and hepatic antioxidant status in spontaneously hypertensive (SHR) and normotensive (WKY) rats. Can J Physiol Pharmacol 76: 202-209, 1998.
38. Koska J, Syrova D, Blazicek P, Marko M, Grna JD, Kvetnansky R, and Vigas M. Malondialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension. J Hypertens 17: 529-535, 1999.
39. Kumar CA and Das UN. Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension. Clin Res 6: 901-907, 2000.
40. MacKnight JM. Exercise considerations in hypertension, obesity, and dyslipidemia. Clin Sports Med 22: 101-121, 2003.
41. Marque V, Kieffer P, Atkinson J, and Lartaud-Idjouadiene I. Elastic properties and composition of the aortic wall in old spontaneously hypertensive rats. Hypertension 34: 415-422, 1999.
42. Martinez-Cayuela M. Oxygen free radicals and human disease. Biochemie 77: 147-161, 1995.
43. Mates JM, Pérez-Gómez C, and Nuñez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 32: 595-603, 1999.
44. Medvedev ZA. An attempt at a rational classification of theories of ageing. Biol Rev Camb Philos Soc 65: 375-398, 1990.
45. Meeks WM. Pathophysiology of hypertension in the elderly. Semin Nephrol 22: 65-70, 2002.
46. Meydani M. Dietary antioxidants modulation of aging and immune-endothelial cell interaction. Mech Ageing Dev 111: 123-132, 1999.
47. Mills PJ, Farag NH, Hong S, Kennedev BP, Berry CC, and Ziegler MG. Immune cell CD62L and CD11a expression in response to a psychological Stressor in human hypertension. Brain Behav Immunol 17: 260-267, 2003.
48. Miquel J. An integrative theory of aging as the result of mitochondrial DNA mutation in differentiated cells. Arch Gerontol Geriatr 12: 99-117, 1991.
49. Miquel J. Can antioxidant diet supplementation protect against age-related mitochondrial damage? Ann N Y Acad Sci 959: 508-516, 2002.
50. Miquel J, Economos AC, Fleming J, and Johnson JE. Mitochondrial role in cell aging. Exp Gerontol 15: 575-591, 1980.
51. Mooradian AD and Uko-Enin A. Age-related changes in the antioxidative potential of cerebral microvessels. Brain Res 671: 159-163, 1995.
52. Muda P, Kampus P, Zilmer M, Zilmer K, Kairane C, Ristimäe T, Fischer K, and Teesalu R. J Hypertens 21: 2329-2333, 2003.
53. Nava M, Quiroz Y, Vaziri N, and Rodriguez-Iturbe B. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 284: F447-F454, 2003.
54. Nelson CR and Knapp DA. Trends in antihypertensive drug therapy of ambulatory patients by U.S. office-based physicians. Hypertension 36: 600-603, 2000.
55. Niess AM, Dickhuth HH, Northoff H, and Fehrenbach E. Free radicals and oxidative stress in exercise-immunological aspects. Exerc Immunol Rev 5: 22-56, 1999.
56. Pamplona R and Barja G. Aging rate, mitochondrial free radical production, and constitutive sensitivity to lipid peroxidation: insights from comparative studies. In: Aging Molecular Level, edited by von Zglinicki T. Amsterdam, The Netherlands: Kluwer Academic Publishers, 2003, pp. 47-64.
57. Parissis JT, Korovesis S, Giazitzoglou E, Kalivas P, and Katritsis D. Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlation with plasma endothelin-1. Int J Cardiol 83: 13-21, 2002.
58. Payne JA, Reckelhoff JF, and Khalil RA. Role of oxidative stress in age-related reduction of NO-cGMP-mediated vascular relaxation in SHR. Am J Physiol Regul Integr Comp Physiol 285: R542-R551, 2003.
59. Pedersen BK and Hoffman-Goetz L. Exercise and the immune system: regulation, integration and adaptation. Physiol Rev 80: 1055-1081, 2000.
60. Pedro-Botet J, Covas MT, Martín S, and Rubiés-Prat J. Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens 14: 343-345, 2000.
61. Plante GE. Impact of aging on the body's vascular system. Metabolism 52: 31-35, 2003.
62. Polidori MC, Mecocci P, Cherubini A, and Senin U. Physical activity and oxidative stress during aging. Int J Sports Med 21: 154-157, 2000.
63. Powers SK, Ji LL, and Leeuwenburgh C. Exercise training-induced alterations in skeletal muscle antioxidant capacity: a brief review. Med Sci Sports Exerc 31: 987-997, 1999.
64. Rall LC, Roubenoff R, Cannon JG, Abad LW, Dinarello CA, and Meydani SN. Effects of progressive resistance training on immune response in aging and chronic inflammation. Med Sci ports Exerc 28: 1356-1365, 1996.
65. Rankinen T and Bouchard C. Genetics and blood pressure response to exercise, and its interactions with adiposity. Prev Cardiol 5: 138-144, 2002.
66. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, and Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341-346, 2003.
67. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, and Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286: F606-F616, 2004.
68. Rodríguez-Martínez MA, García-Cohen EC, Briones A, Baena AB, Marín E, Salaices M, and Marín J. Changes in plasma oxidative state with age and their influence on contractions elicited by noradrenaline in the rat tail artery. Life Sci 65: 915-924, 1999.
69. Rodriguez-Porcel M, Herrman J, Chade AR, Krier JD, Breen JF, Lerman A, and Lerman LO. Long-term antioxidant intervention improves myocardial microvascular function in experimental hypertension. Hypertension 43: 493-498, 2004.
70. Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, Lombardi S, and Corrocher R. Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16: 1267-1271, 1998.
71. Sastre J, Pallardo FV, Garcia de la Asuncion J, and Viña J. Mitochondria, oxidative stress and aging. Free Radic Res 32: 189-198, 2000.
72. Schiffrin EL, Park JB, Intengan HD, and Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101: 1653-1659, 2000.
73. Shinkat S, Konishi M, and Shephard RJ. Aging, exercise, training and the immune system. Exerc Immunol Rev 3: 68-95, 1996.
74. Smith JA and Pyne DB. Exercise, training and neutrophil function. Exerc Immunol Rev 3: 96-117, 1997.
75. Stewart KJ. Exercise training and the cardiovascular consequence of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health. JAMA 288: 1622-1631, 2002.
76. Suematsu M, Suzuki H, Delano FA, and Schmid-Schönbein GW. The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation 9: 259-276, 2002.
77. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, and Lejemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28: 964-971, 1996.
78. Touyz RM. Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 1: 91-106, 2003.
79. Túri S, Friedman A, Bereczki C, Papp F, Kovàcs J, Karg E, and Németh T. Oxidative stress in juvenile essential hypertension. J Hypertens 21: 145-152, 2003.
80. Varagic J, Susic D, and Frohlich E. Heart, aging and hypertension. Curr Opin Cardiol 16: 336-341, 2001.
81. Vaziri ND, Ni Z, Oveisi F, and Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 36: 957-964, 2000.
82. Veerappan RM, Senthil S, Rao MR, Ravikumar R, and Pugalendi KV. Redox status and lipid peroxidation in alcoholic hypertensive patients and alcoholic hypertensive patients with diabetes. Clin Chim Acta 340: 207-212, 2004.
83. Víctor VM, Rocha M, and De la Fuente M. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 4: 327-347, 2004.
84. Wallace JP. Exercise in hypertension. A clinical review. Sports Med 33: 585-598, 2003.
85. Wayne SJ, Rhyne RL, Garry PJ, and Goodwin JS. Cell-mediated immunity as a predictor of morbidity and mortality in subjects over 60. J Gerontol 45: M45-M48, 1990.
86. Wilczynski JR, Banasik M, Tchórzewski H, Glowacka E, Malinowski A, Szpakowski M, Lewkowicz P, Wieczorek A, Zeman K, and Wilczynski J. Expression of intracellular adhesion molecule-1 on the surface of peripheral blood and decidual lymphocytes of women with pregnancy-induced hypertension. Eur J Obstet Gynecol Reprod Biol 102: 15-20, 2002.
87. Yargiçoglu P, Gümüslüoriob S, Agar A, Korgun DK, and Küçükatay V. Effect of sulfur dioxide inhalation on erythrocyte antioxidant status, food intake, and lipid peroxidation during aging. Arch Environ Health 56: 53-57, 2001.
88. Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J, and Asada A. Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension. Am J Med 116: 460-465, 2004.